Takahiro Maruta

400 total citations
23 papers, 299 citations indexed

About

Takahiro Maruta is a scholar working on Neurology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Takahiro Maruta has authored 23 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 6 papers in Molecular Biology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Takahiro Maruta's work include Myasthenia Gravis and Thymoma (12 papers), Peripheral Neuropathies and Disorders (8 papers) and Parkinson's Disease and Spinal Disorders (3 papers). Takahiro Maruta is often cited by papers focused on Myasthenia Gravis and Thymoma (12 papers), Peripheral Neuropathies and Disorders (8 papers) and Parkinson's Disease and Spinal Disorders (3 papers). Takahiro Maruta collaborates with scholars based in Japan, United States and Ireland. Takahiro Maruta's co-authors include Masaharu Takamori, M. Zouhair Atassi, Minako Oshima, Kiyonobu Komai, Dennis R. Mosier, Kaiping Xu, Werner Hoch, Smita Jha, Hiroaki Yoshikawa and Masahito Yamada and has published in prestigious journals such as Neurology, Clinical Neurophysiology and Journal of the Neurological Sciences.

In The Last Decade

Takahiro Maruta

22 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takahiro Maruta Japan 11 211 56 49 47 37 23 299
Donato Sauchelli Italy 6 81 0.4× 29 0.5× 84 1.7× 31 0.7× 17 0.5× 9 195
D. Orrico Italy 11 89 0.4× 27 0.5× 35 0.7× 58 1.2× 29 0.8× 17 237
Wibke Johannis Germany 7 138 0.7× 32 0.6× 35 0.7× 35 0.7× 6 0.2× 16 229
Sayuri Shima Japan 10 165 0.8× 16 0.3× 55 1.1× 93 2.0× 15 0.4× 50 331
John A. Morren United States 10 222 1.1× 32 0.6× 43 0.9× 23 0.5× 7 0.2× 27 324
Elba Pascual‐Goñi Spain 10 218 1.0× 46 0.8× 18 0.4× 69 1.5× 21 0.6× 22 272
Tomohiko Nakata Japan 10 104 0.5× 31 0.6× 156 3.2× 52 1.1× 60 1.6× 33 336
Jeffrey O’Callaghan Ireland 9 118 0.6× 45 0.8× 123 2.5× 17 0.4× 10 0.3× 16 406
Grace Gombolay United States 11 178 0.8× 45 0.8× 25 0.5× 25 0.5× 7 0.2× 41 319
Ana Felipe‐Rucián Spain 5 226 1.1× 33 0.6× 69 1.4× 56 1.2× 23 0.6× 15 290

Countries citing papers authored by Takahiro Maruta

Since Specialization
Citations

This map shows the geographic impact of Takahiro Maruta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takahiro Maruta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takahiro Maruta more than expected).

Fields of papers citing papers by Takahiro Maruta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takahiro Maruta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takahiro Maruta. The network helps show where Takahiro Maruta may publish in the future.

Co-authorship network of co-authors of Takahiro Maruta

This figure shows the co-authorship network connecting the top 25 collaborators of Takahiro Maruta. A scholar is included among the top collaborators of Takahiro Maruta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takahiro Maruta. Takahiro Maruta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maruta, Takahiro, Minako Oshima, Dennis R. Mosier, & M. Zouhair Atassi. (2017). Injection of inactiveBordetella pertussisand complete Freund’s adjuvant withTorpedo californicaAChR increases the occurrence of experimental autoimmune myasthenia gravis in C57BL/6 mice. Autoimmunity. 50(5). 293–305. 2 indexed citations
3.
Oshima, Minako, Akiko Iida‐Klein, Takahiro Maruta, Philip R. Deitiker, & M. Zouhair Atassi. (2017). Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice. Autoimmunity. 50(6). 346–353. 2 indexed citations
6.
Yokoyama, Shigeru, Takahiro Maruta, Akiko Muroyama, et al.. (2013). Autoantibody-induced internalization of nicotinic acetylcholine receptor α3 subunit exogenously expressed in human embryonic kidney cells. Journal of Neuroimmunology. 257(1-2). 102–106. 17 indexed citations
7.
Sakamoto, Aiko, Miyuki Yamamoto, Masao Takahashi, et al.. (2010). A case of myasthenia gravis with cardiac fibrosis and easily provoked sustained ventricular tachycardia. Journal of Cardiology Cases. 2(1). e41–e44. 3 indexed citations
8.
Iwasa, Kazuo, Yutaka Furukawa, Takahiro Maruta, et al.. (2010). Up-regulation of MHC class I and class II in the skeletal muscles of myasthenia gravis. Journal of Neuroimmunology. 225(1-2). 171–174. 10 indexed citations
9.
Maruta, Takahiro, et al.. (2009). Autoantibody to dihydropyridine receptor in myasthenia gravis. Journal of Neuroimmunology. 208(1-2). 125–129. 9 indexed citations
10.
Nakata, Miho, Satoshi Kuwabara, Naoki Kawaguchi, et al.. (2007). Is excitation–contraction coupling impaired in myasthenia gravis?. Clinical Neurophysiology. 118(5). 1144–1148. 10 indexed citations
11.
Maruta, Takahiro, Behzod Z. Dolimbek, K. Roger Aoki, & M. Zouhair Atassi. (2006). Inhibition by human sera of botulinum neurotoxin-A binding to synaptosomes: A new assay for blocking and non-blocking antibodies. Journal of Neuroscience Methods. 151(2). 90–96. 11 indexed citations
12.
Yoshikawa, Hiroaki, Katsuaki Sato, Yutaka Furukawa, et al.. (2006). Elevation of IL-12 p40 and its antibody in myasthenia gravis with thymoma. Journal of Neuroimmunology. 175(1-2). 169–175. 15 indexed citations
13.
Maruta, Takahiro, Minako Oshima, Philip R. Deitiker, Maki Ohtani, & M. Zouhair Atassi. (2006). Use of Alum and InactiveBordetella pertussisfor Generation of Antibodies Against Synthetic Peptides in Mice. Immunological Investigations. 35(2). 137–148. 3 indexed citations
14.
Jha, Smita, Kaiping Xu, Takahiro Maruta, et al.. (2006). Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK). Journal of Neuroimmunology. 175(1-2). 107–117. 83 indexed citations
15.
Oshima, Minako, et al.. (2005). Vaccination with a MHC class II peptide in Alum and inactive pertussis strongly ameliorates clinical MG in C57BL/6 mice. Journal of Neuroimmunology. 171(1-2). 8–16. 6 indexed citations
16.
Maruta, Takahiro, Behzod Z. Dolimbek, K. Roger Aoki, Lance E. Steward, & M. Zouhair Atassi. (2004). Mapping of the Synaptosome-Binding Regions on the Heavy Chain of Botulinum Neurotoxin A By Synthetic Overlapping Peptides Encompassing the Entire Chain. The Protein Journal. 23(8). 539–552. 23 indexed citations
17.
Takamori, Masaharu & Takahiro Maruta. (2001). Immunoadsorption in Myasthenia Gravis Based on Specific Ligands Mimicking the Immunogenic Sites of the Acetylcholine Receptor. Therapeutic Apheresis. 5(5). 340–350. 22 indexed citations
18.
Takamori, Masaharu, Takahiro Maruta, & Kiyonobu Komai. (2000). Lambert–Eaton myasthenic syndrome as an autoimmune calcium-channelopathy. Neuroscience Research. 36(3). 183–191. 24 indexed citations
19.
Takamori, Masaharu & Takahiro Maruta. (2000). [Receptor diseases in the field of neurology].. PubMed. 48(5). 385–95. 3 indexed citations
20.
Maruta, Takahiro, Makoto Nihira, & York Tomita. (1997). [Histopathological study on acute poisoning of methamphetamine, morphine or cocaine].. PubMed. 32(2). 122–38. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026